SEC Form D · filed February 6, 2023
ZETAGEN THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Ashok C. Kaveeshwar · Bethesda, MDDirectorNikhil Thakur, Md · Andover, MAExec · DirectorJoe C. Loy · Weatherford, TXDirectorPeter B. Finn · Boston, MAExecDonald C. Brown · Hopkinton, MADirectorRichard C. Warburg · Bethesda, MDDirectorMichael J. Stark · Menlo Park, CADirectorHans Miller · Arlington, VAExecNicholas Bienstock · New York, NYDirectorRobert Poulin · Arlington, VAExec · DirectorMichael D. Hankin · Baltimore, MDDirectorWilliam O. White · Baltimore, MDDirectorAndrew Levin · Boston, MAExecJoshua Resnick · Boston, MAExec · DirectorGregory M. Gentile · New York, NYDirectorSteven Sordello · New York, NYDirectorTodd Crow · Portland, ORDirectorSteve Wolin · Minneapolis, MNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗